106 related articles for article (PubMed ID: 9886594)
1. Analysis of the peripheral blood lymphocyte subsets in patients with bladder carcinoma.
Soygür T; Bedük Y; Yaman O; Yilmaz E; Tokgöz G; Gögüş O
Urology; 1999 Jan; 53(1):88-91. PubMed ID: 9886594
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.
Kastelan Z; Lukac J; Derezić D; Pasini J; Kusić Z; Sosić H; Kastelan M
Anticancer Res; 2003; 23(6D):5185-9. PubMed ID: 14981987
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of peripheral blood lymphocyte subsets in patients with bladder carcinoma treated using neoadjuvant M-VEC chemotherapy.
Soygür T; Bedük Y; Baltaci S; Yaman O; Tokgöz G
BJU Int; 1999 Dec; 84(9):1069-72. PubMed ID: 10571638
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocyte subsets in urinary bladder carcinoma patients.
Gaafar T; Lotfy M; el Ridi R
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):511-7. PubMed ID: 1726772
[TBL] [Abstract][Full Text] [Related]
6. [RBC and T lymphocyte subsets in patients with bladder carcinoma: immunological study].
Xu J; Zhang Y
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):113-6. PubMed ID: 11829798
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
8. T lymphocyte subsets and function in the peripheral blood of patients with urological cancer.
Kaver I; Pecht M; Trainin N; Greenstein A; Braf Z
Oncology; 1992; 49(2):108-13. PubMed ID: 1574245
[TBL] [Abstract][Full Text] [Related]
9. Characterization of peripheral blood T-cell subpopulation of bladder cancer patients.
Greenstein A; Pecht M; Kaver I; Trainin N; Braf Z
Urol Res; 1991; 19(4):219-22. PubMed ID: 1926656
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder.
Agarwal A; Verma S; Burra U; Murthy NS; Mohanty NK; Saxena S
Cancer Immunol Immunother; 2006 Jun; 55(6):734-43. PubMed ID: 16283306
[TBL] [Abstract][Full Text] [Related]
11. Keyhole limpet hemocyanine can enhance the natural killer activity of patients with transitional cell carcinoma of the bladder.
Moltó LM; Carballido J; Jurincic C; Lapeña P; Manzano L; Salmerón I; Klippel KF; Alvarez-Mon M
Eur Urol; 1991; 19(1):74-8. PubMed ID: 2007423
[TBL] [Abstract][Full Text] [Related]
12. Use of intracavitary interferon-alpha-2b in the prophylactic treatment of patients with superficial bladder cancer.
Moltó L; Alvarez-Mon M; Carballido J; Olivier C; Gimeno F; Manzano L
Cancer; 1995 Jun; 75(11):2720-6. PubMed ID: 7743476
[TBL] [Abstract][Full Text] [Related]
13. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated.
Reyes E; Carballido J; Prieto A; Molto L; Manzano L; Alvarez-Mon M
Eur Urol; 1997; 31(4):472-7. PubMed ID: 9187910
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.
Carballido J; Alvarez-Mon M; Solovera OJ; Menéndez-Ondina L; Durántez A
J Urol; 1990 Jan; 143(1):29-33. PubMed ID: 2294256
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
Mizutani Y; Okada Y; Terachi T; Yoshida O
J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder.
Britten V; Rees RC; Clegg A; Smith GT; Potter CW; Fox M; Williams JL
Br J Urol; 1982 Jun; 54(3):261-6. PubMed ID: 7104588
[TBL] [Abstract][Full Text] [Related]
17. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
18. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
Moroz C; Madgar I; Twig S; Lindner A; Many M
Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847
[TBL] [Abstract][Full Text] [Related]
19. Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer.
Morita T; Tokue A; Minato N
Cancer Immunol Immunother; 1990; 32(3):191-4. PubMed ID: 1705177
[TBL] [Abstract][Full Text] [Related]
20. Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.
Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
J Urol; 1988 Oct; 140(4):890-4. PubMed ID: 3262173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
